A large variety of adjuvant and neoadjuvant treatment concepts were develop
ed during the recent years to improve the results of gastrointestinal tumor
s. Three exist generally accepted guidelines for adjuvant treatment of colo
n and rectal cancer, while for the tumors of the upper gastrointestinal tra
ct convincing results of randomized studies are still missing. Therefore on
going and future studies have to find out, which patients could have a bene
fit from multimodal therapy.